C9069 Injection, belantamab mafodontin-blmf, 0.5 mg

Short descriptor: Belantamab mafodontin-blmf

⚠ Terminated HCPCS Level II 2026
Terminated Code
C9069 was terminated as of 2021-03-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open C9069 in the app →

Look up C9069 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9069 is the HCPCS Level II code for Injection, belantamab mafodontin-blmf, 0.5 mg (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Statute (indicator 53)
Type of Service
Other medical items or services
Effective Date
2021-04-01
Termination Date
2021-03-31
2026 Maintenance
No change this year

References

Cite This Page

Reference C9069 with the canonical source and edition:

C9069 — Injection, belantamab mafodontin-blmf, 0.5 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9069

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9069

Related Codes in Section C

← C9068 Copper cu-64, dotatate, dx C9070 → Injection, tafasitamab-cxix
C9065 Romidepsin non-lyophilized C9066 Sacituzumab govitecan-hziy C9067 Gallium ga-68 dotatoc C9068 Copper cu-64, dotatate, dx C9070 Injection, tafasitamab-cxix C9071 Injection, viltolarsen C9072 Inj, imm glob asceniv C9073 Brexucabtagene autoleucel ca C9074 Injection, lumasiran C9075 Injection, casimersen, 10 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial